References
- Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. Glucocorticoids increase amyloid-fl and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 2006; 26: 9047–56.
- Clemens JA, Stephenson DT. Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol Aging 1992; 13: 581–6.
- Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988; 38: 1682–7.
- Snowdon DA. Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist 1997; 37: 150–6.
- Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NP, Meaney MJ. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 1994; 14: 2893–903.
- Lupien SJ, Wilkinson CW, Brière S, Ng Ying Kin NMK, Meaney MJ, Nair NPV. Acute modulation of aged human memory by pharmacological manipulation of glucocorticoids. J Clin Endocrinol Metab 2002; 87: 3798–807.
- Yao YY, Liu DM, Xu DF, Li WP. Memory and learning impairment induced by dexamethasone in senescent but not young mice. Eur J Pharmacol 2007; 574: 20–28.
- Pierrot N, Santos SF, Feyt C, Morel M, Brion J-P, Octave JN. Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-fl accumulation. J Biol Chem 2006; 281: 39907–14.
- Drapeau E, Mayo W, Aurousseau CA, Le Moal M, Piazza P-V, Abrous DN. Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. PNAS 2003; 100: 14385–90.
- Williamson R, Scales T, Clark BR, Gibb G, Reynolds CH, Kellie S, et al. Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-fl peptide exposure: involvement of Src family protein kinases. J Neurosci 2002; 22: 10–20.
- Chen SJ, Opera& T, Bonzo J, Nguyen N, Tukey RH. ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degrada-tion. J Biol Chem 2005; 280: 4350–9.
- Linseman DA, Cornejo BJ, Le SS, Meintzer MK, Laessig TA, Bouchard RJ, et al. A myocyte enhancer factor 2D (MEF2D) kinase activated during neuronal apoptosis is a novel target inhibited by lithium. J Neurochem 2003; 85: 1488-99.
- Xu J, Chen S, Ku G, Ahmed SH, Xu J, Chen H, etal. Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J Cereb Blood Flow Metab 2001; 21: 702–10.
- McEwen BS, De Kloet ER, Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol Rev 1986; 66: 1121–88.
- Quervain DJF, Poirier R, Wollmer MA, Grimaldi LME, Tsolaki M, Streffer JR, et al. Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum Mol Genet 2004; 13: 47–52.
- Toshiaki I, Hidefumi F, Yoshikage M, Nishimura M. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3 in N1E-115 neuroblastoma cells. J Biol Chem 2003; 278: 26970–5.
- Wang HY, Li WW, Benedetti NJ, Lee DHS. α7 nicotinic acetylcholine receptors mediate J3-amyloid peptide-induced tau protein phosphorylation. J Biol Chem 2003; 278: 31547–53.